MOLECULAR GENETIC DETECTION OF BACTERIAL VAGINOSIS AT KAZAKHWOMEN IN REPRODUCTIVE AGE by Oradova, Axoltan & Duyssembayev, Bilimzhan
European Scientific Journal   December 2013 /SPECIAL/ edition vol.3  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
 
264 
 
MOLECULAR GENETIC DETECTION OF BACTERIAL 
VAGINOSIS AT KAZAKH WOMEN IN REPRODUCTIVE 
AGE 
 
 
 
Axoltan Oradova, PhD 
Bilimzhan Duyssembayev, PhD, Associate Prof. 
Kazakh National Medical University named by S.D.Asfendiyarov,Almaty, Kazakhstan 
Central Clinical Hospital Medical Center of President's Affairs Administration of 
Republic of Kazakhstan Almaty, Kazakhstan 
 
 
Abstract 
Introduction: The diagnostic of sexually transmitted infection (STI) sharply increased. 
Steady growth of STI at persons of young age, women of fertility age who are often 
accompanied by the complications leading to disability, to infertility, a pre-natal infection is 
observed, causing fruit and newborn diseases. The purpose of our study was to analyze the 
molecular genetic detection of bacterial vaginosis at women in reproductive age by 
noninvasive methods.  
Materials and Methods: Total DNA was isolated was extracted from vaginal samples at 54 
women between the ages of 15 and 45 years who were able and willing to give informed 
consent. The analysis of products of PCR of amplification carried out by PCR in real time. 
Results: It is revealed that associations bacterial vaginosis less often met three infectious 
agents in comparison with one and two (18, 5±3, 5 %, 38,9±6,3 %, 42,6±6,5 %, respectively, 
(р<0,05).  
Conclusion: Our study demonstrates that, using a panel of DNA by means of PCR in real time 
the identification of BV patients with minimally invasive techniques. 
 
Keywords: Bacterial vaginosis (BV), polymerase chain reaction real time (PCR-RT), 
sexually transmitted infection (STI), inflammatory diseases of bodies of a small basin 
(IDBSB), morbidity and mortality 
 
Introduction  
Bacterial vaginosis (BV) is a common cause of vaginal discharge in women of 
reproductive age [1]. In fact, numerous observational studies cite BV as the most common 
cause of symptomatic vaginal discharge during reproductive years with a prevalence of 10–
15% [2]. Depending on geographic, racial, and clinical characteristics of a given population; 
BV has been observed to exhibit a wide-ranging prevalence from 4 to 64%. A total of 800 000 
pregnancies in the USA are affected by BV annually [3]. Similar prevalence exists in both the 
pregnant and non-pregnant states. Asymptomatic women, whether pregnant or not, exhibit a 
prevalence of 12–25% [4].  
Diagnosis in the clinical setting is accomplished by two common methods: microscopic 
examination of vaginal discharge for clue cells and Whiff Test (sometimes referred to as the 
‘sniff test’) in which KOH (potassium hydroxide) is applied to a vaginal swab to detect a 
release of amine odor that is sniffed by the clinician. The Whiff Test is deemed positive when 
an amine odor, sometimes described as similar to that of decaying fish, is sensed by the 
clinician [5]. Investigation by Hillier (nј 2000) showed microscopic finding of clue cells to be 
43.1% sensitive and 99.6% specific for presence of BV. The same investigation showed the 
Whiff Test to be 6.58% sensitive and 73.6% specific for BV [6]. The Amsel criteria for 
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diagnosis of BV include the following: vaginal pH > 4.5, abnormal discharge, clue cells, and 
positive sniff test.5 Presence of three out of four criteria is considered to be diagnostic for BV 
in the clinical setting. The gold standard for BV screening in investigations is the Nugent 
score which entails generation of a scaled score 0–10 in which 0–3 is negative, 4–6 is 
intermediate, and _7 is positive for BV [7].  
In recent years the importance of sexually transmitted infection (STI) sharply increased. 
Steady growth of STI at persons of young age, women of fertility age who are often 
accompanied by the complications leading to disability, to infertility, a pre-natal infection is 
observed, causing fruit and newborn diseases. One of the aspects testifying to the high 
importance of STI, their influence on the course of pregnancy, its outcomes and a state of 
health of the newborn is. According to the Centers for control of diseases (the CDC USA), at 
pregnant women most often come to light such STI as bacterial vaginosis (BV), the herpetic 
and chlamydial infection, is more rare trichomoniasis, gonorrhea, syphilis and HIV infection. 
However frequency of the perinatal infection connected with separate STI, is defined not only 
their prevalence in population, but also transmission frequency. The risk of perinatal infection 
makes about 30 % for gonococcus, 20-50 % for mycoplasma, 20-40 % for chlamydia, 5-50 % 
for a herpetic infection and about 50 % for syphilis. The risk of perinatal infection of the 
newborn is highest at a sharp primary infection [8]. 
Despite ambiguity of opinions of researchers in an pathogenic role of Ureaplasma spp. 
and Mycoplasma hominis, in etiological classification of World Health Organization [9] 
and sindromaly classification of Centers for Disease Control and Prevention [10] these 
microorganisms are allocated as possible etiological agents nonspecific not gonokokkal 
urethritis, inflammatory diseases of bodies of a small basin and bacterial vaginosis. Without 
adequate therapy at a third of the infected women develop IDBSB [11]. The question of what 
conditions are decisive for realization of pathogenic potential of opportunistic 
mycoplasmas, so far remains obscure. Numerous researches testify that it is possible to judge 
an etiological role of the specified activators with this or that share of probability only by 
results of the quantitative analysis. The standardized approaches to laboratory verification of 
the diagnosis of a urogenital infection are developed insufficiently. 
The aim of this study is to determine the sensitivity, specificity and the predictive value 
of the BV and to observe the risk factors associated in the study of 54 women with BV in 
association with pathogenic and/or opportunistic causative agents of infections of a urogenital 
path (Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis). 
 
Materials and Methods:  
This enrollment began conducted in molecular-genetic laboratory at Scientifically 
Research Institute of Fundamental and Applied Medicine named by B. Atchabarov 
(SRIFAM) of Kazakh National Medical University named by S.D. Asfendiyarov, Almaty, 
(KAZNMU), Kazakhstan from September 2011 to December 2011. Funded by Ministry of 
Education and Science of (Republic of Kazakhstan) Grant: No. of state registration 
0111PK00487 2011. Women that were eligible for project included Russian-speaking women 
between the ages of 15 and 45 years who were able and willing to give informed consent. 
Informed consent was received for all participants who were 18 years old.  
As a result of the conducted complex laboratory testing at 96 (65, 8 %) women at the 
time of the address it was diagnosed bacterial vaginosis and at 50 (34, 2%) - a normal state of 
microflora of a vagina (control group). 96 patients with bacterial vaginosis were divided into 
3 groups: 
Group I - 30 (31, 3%) women with bacterial vaginosis; 
Group II - 12 (12, 5%) women with bacterial vaginosis in association with Candidiasis 
vulvovaginitis; 
European Scientific Journal   December 2013 /SPECIAL/ edition vol.3  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
 
266 
 
Group III - 54 (56, 3%) women with bacterial vaginosis in association with pathogenic 
and/or opportunistic causative agents of infections of a urogenital path (Chlamydia 
trachomatis, Ureaplasma urealyticum and Mycoplasma hominis).  
Selection criteria in group of patient’s bacterial vaginosis were: reproductive age; lack 
of pregnancy and lactation; lack of system and local antibacterial therapy within 1 month 
before the real inspection; clinical-microbiological confirmation of the diagnosis bacterial 
vaginosis; existence of complaints. 
Selection criteria of patients in control group were: reproductive age; lack of pregnancy 
and lactation; lack of system and local antibacterial therapy within 1 month before the real 
inspection; clinic microbiological confirmation of a normal state of vaginal microflora and 
excluded STD; absence of complaints. 
At the baseline and follow-up visits, a trained nurse conducted a physical examination 
(including a pelvic examination) and collected endocervical specimens for testing for sexually 
transmitted infections. Women with bacterial or protozoan STIs were treated according to 
CDC guidelines [12]. 
Total DNA from vaginal samples was isolated using the DNA sorb-AM nucleic acid 
extraction kit (AmpliSens) according to the manufacturer’s guidelines. DNA was allocated on 
an amplificatory "Rotor-Gene 6000 (Corbett Research, Australia) by set of reagents for DNA 
identification in a clinical material a method of PCR with gibridization-fluorescent 
detection of «Amplisens® Chlamydia trachomatis/ Ureaplasma urealyticum /Mycoplasma 
hominis-FL». The total volume PCR out amount of a reactionary mix – 30 mkl, including the 
volume of test of DNA – 10 mkl. The DNA was amplified using the following protocol « 
AmpliSens - 1»: an initial denaturation (95 ◦C for 15min), followed by 5 cycles of 
denaturation (95 ◦C for 5 s), annealing (60 ◦C for 20 s) and extension (72◦ C for 15 s), 
followed by 40 cycles of denaturation (95 ◦C for 5 s), annealing (60 ◦C for 20 s) with a final 
fluorescence detection and extension (72◦ C for 15 s). The diagnostic value of a set for 
detection of microorganisms in concentration more than 103 colony constitutive units in 1 ml. 
When using sets of reagents for identification of DNA of each microorganism analyze 
curve accumulation of a fluorescent signal on two channels: 
- on the channel for a fluorofor of FAM the signal testifying to accumulation of a product of 
amplification of a fragment of DNA of the revealed microorganism is registered, 
- on the channel for a fluorofor of JOE the signal testifying to accumulation of a product of 
amplification of DNA of eternal control sample is registered. 
Principle of interpretation of results the following 
- DNA of a microorganism is found if for this test in the table of results of the channel for a 
fluorofor of FAM value of the threshold cycle Ct is defined. Thus the curve of fluorescence of 
this test has to cross the threshold line on a site of characteristic exponential lifting of 
fluorescence. 
- DNA of a microorganism isn't found if for this test in the table of results of the channel for a 
fluorofor of FAM it isn't defined there (is) no value of the threshold cycle Ct (the curve of 
fluorescence doesn't cross the threshold line), and in the table of results of the channel for a 
fluorofor of JOE the value of the threshold cycle Ct which isn't exceeding specified 
(boundary) value is defined. 
 
Statistical analysis  
The data were analyzed using criteria Student tests. The results are expressed with 
calculated standard deviations (SD). We considered p values of ≤0,05 to indicate statistical 
significance.  
 
 
 
European Scientific Journal   December 2013 /SPECIAL/ edition vol.3  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
 
267 
 
Results of researches:  
In studied group of women were observed moderated (66, 7±7, 5%), ochroleucous color 
(68, 5±8, 3%), homogeneous (70, 4±11,2 in %), viscous (70,4±11,2 in %) allocation from 
sexual ways more often. At survey of mucous membranes of genitals the vagina hyperemia 
(48, 1±6, 7 %) and uterus necks (59, 3±7, 1 %) more often came to light, and also contact 
bleeding of a neck of a uterus (50, 0±6,4 by %) was noted. At bimanual survey more often in 
this group of women morbidity and increase in appendages of a uterus, existence of adhesive 
process in a small basin (51, 9±6, 6 by % and 70, 4±11, 2 in %, respectively), (р<0,05). 
Table 1 - Results of a combination bacterial vaginosis with pathogenic and/or opportunistic microorganisms 
Infectious agents Number of patients (N=54) 
Absolute number  % 
Chlamydia trachomatis 32 59,3±7,1 
Ureaplasma urealyticum 39 72,2±11,4* 
Mycoplasma hominis 26 48,1±6,7 
Association bacterial vaginosis with: 
One infectious agent 21 38,9±6,3 
Two infectious agents 23 42,6±6,5 
Three infectious agents 10 18,5±3,5* 
Remarks:* - distinctions are authentic, р< 0,05 
 
Discussion of results:  
Apparently from the presented data in table 1, in studied group of women the PCR 
method and/or a cultural method with a quantitative assessment found Chlamydia trachomatis 
at 32 (59, 3±7, 1 %) patients, U. urealyticum at 39 (72,2 ±11,4 %) and M. hominis in high 
titers – at 26 (48,1± 6,7 %). It is revealed that is more often bacterial vaginosis associated 
with Ureaplasma urealyticum in comparison with Mycoplasma hominis (р<0,05). 
Only Ureaplasma urealyticum in high titers is found at 8 (14, 8 %) the women, only by 
Mycoplasma hominis in high titers – at 5 (9,3 %), only Chlamydia trachomatis – at 8 (14,8 
%).  
Thus, the association bacterial vaginosis with one infectious agent in the studied group 
of women was observed in 21 (38, 9 ± 6, 3 by %) a case. Association with two infectious 
agents - at 23 (42, 6 ± 6, 5 the %) patients, from them at 9 (39, 1 %) bacterial vaginosis was 
combined with Ureaplasma urealyticum and Mycoplasma hominis in high titers, at 12 (52,2 
%) with C. trachomatis and U. urealyticum, at 2 (8,7 %) Chlamydia trachomatis and 
Mycoplasma hominis.  
At 10 (18, 5±3, 5 the %) patients observed association bacterial vaginosis with three 
infectious agents: Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis. 
It is revealed that associations bacterial vaginosis less often met three infectious agents 
in comparison with one and two (18, 5±3, 5 %, 38, 9±6,3 %, 42,6±6,5 %, respectively, 
(р<0,05). 
To important features of urogenital chlamidiosis, besides its not enough symptoms and 
high frequency of complications, often meeting association with other STI activators, and also 
a many loci treats with involvement in pathological process not only urogenital bodies, but 
also quite often rectum, a throat, eyes, joints, heart, skin. 
All 32 patients with the revealed urogenital clamidiosis were surveyed for an exception 
of a many loci of infectious process. Thus, PCR method Chlamydia trachomatis were found in 
rectum – at 15 (46, 9±4, 3 by %), in a oropharynx – at 21 (65, 6±7, 5 in %) women. 
Thus, Chlamydia trachomatis came to light in the urogenital center (an urethra and the 
cervical channel) in comparison with chlamydial defeat rectum and oropharynx (98, 4±9, 3 %, 
46, 9±4, 3 %, 65,6±7,5 %, respectively), (р<0,05) more often. 
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Conclusion 
Recently often applied method of diagnostics of causative agents of urogenital 
infections is PCR, allowing identifying them in liquids and organism fabrics. The method is 
based on the analysis of nucleotide sequence and it is considered the most sensitive (94-100 
%) and specific (97-100 %). The main problem in use of PCR is connected with their 
exclusively high sensitivity of a method that demands observance of rigid rules of work. 
Besides, at interpretation of results, it is necessary to consider that PCR reveals only a small 
part of a genome of a microorganism and, therefore, isn't criterion of its viability [13, 14]. 
We are demonstrated an association between increased severity of BV and the future 
incidence of contracting an STI. Although the use of the scoring systems used in this article 
may not be practical in the hospital, the studies’ conclusions are most helpful in counseling 
the patient, as having all more severe cases of BV puts that patient at risk for future STIs. 
Thus, bacterial vaginosis now it is necessary to consider not only as frequent 
independent nozologycal unit, but also as a background for additional development of STI. In 
this regard the importance has careful laboratory inspection of each patient bacterial vaginosis 
on STI, including carrying out screening on existence of the extra genital centers of a 
chlamydia infection. Attracts attention, what even in the absence of STI, at patient’s bacterial 
vaginosis, besides vagina defeat, signs cervicitis and/or urethritis take place. It can be caused 
by realization of pathogenic properties of opportunistic microorganisms. 
Our study provides support for the interpretation that sexual behavior has a causal role 
in the development of BV. Whereas this study was not designed to track the transmission of 
specific microorganisms that might be necessary for the development of BV, the longitudinal 
design and the data analysis allowed to separately assess three possible causal links: 1) that 
sexual behavior commonly associated with the acquisition of STIs is also associated with the 
development of BV; 2) that the acquisition of STIs is a risk factor for the subsequent 
development of BV; and  factor for incident three infectious agents) differed in their 
associations with the two study outcomes, supporting the hypothesis of a similar etiologic role 
of sexual behavior in the acquisition of STIs and BV. 
Although this study is somewhat limited by both the inherent recall bias of the 
participants and the recognized fact that young women tend to underreport sexual behaviors, 
it does add to a growing body of evidence that supports BV as a 
sexually transmitted illness. Findings are consistent with a causal role of sexual behavior in 
the acquisition of BV and confirm that BV facilitates acquisition of three infectious agents 
and vice versa independently from other risk factors. An important note is that Gram staining 
results are compatible with PCR results, since this method is fast, easy and inexpensive, so 
that it could be used in developing countries, where and when molecular techniques are not 
available. The high frequency in Kazakh young women found in this study is alarming, since 
BV increases woman’s susceptibility to HIV, HPV and other important sexually transmitted 
diseases. Therefore BV has to be correctly and timely diagnosed in order to be adequately 
treated. Further investigations regarding other pathogens involved in BV such as A. vaginae 
and Mobiluncus spp. are warranted. 
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